GlassScriptPhysician profile
Racheal Peterson
NPI 1760845879
$3,257.27
in general payments reported to CMS, 2019-2025
12 companies · $1,691 in 2025
The $1,691 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,464 · 2024: $102 · 2025: $1,691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,734 · Food and Beverage: $1,523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,734.10 |
| Food and Beverage | $1,523.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,402.94 | 2023-2024 | Core, N/A, Omnicurve |
| Spineology INC. | $839.78 | 2025 | |
| Medtronic, INC. | $315.95 | 2024-2025 | Mazor X System, Unid_pass, T2 Stratosphere Expandable Corpectomy System |
| Novapproach Spine, LLC | $239.75 | 2025 | Onelif |
| Boston Scientific Corporation | $175.17 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management, Artisan |
| Integra Lifesciences Corporation | $144.69 | 2023-2025 | Codman Hakim, Cusa Clarity, Codman Certas |
| Convatec INC. | $27.91 | 2025 | |
| Ossdsign USA Incorporated | $23.96 | 2025 | Ossdsign Catalyst |
| Longeviti Neuro Solutions INC | $23.49 | 2025 | Clearfit |
| Providence Medical Technology, INC. | $22.33 | 2025 | |
| Abbott Laboratories | $22.31 | 2025 | Infinity |
| Aesculap, INC. | $18.99 | 2023 | Aesculap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Racheal Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.